Baxter International Inc. · 12 hours ago
Senior Director Growth Strategy & Corporate Transformation (ONSITE),
Baxter International Inc. is committed to redefining healthcare delivery and empowering individuals to make a meaningful impact. The Senior Director of Growth Strategy & Corporate Transformation will lead enterprise-wide initiatives and program management efforts to optimize business resources and drive transformation across the organization.
BiotechnologyClinical TrialsHealth CareMedical
Responsibilities
Partner with the Transformation Lead to shape and evolve the overarching transformation vision and roadmap
Translate strategic priorities into clearly defined workstreams, KPIs, and ownership structures
Ensure prioritization of initiatives aligns with enterprise goals
Drive synthesis and storytelling across transformation efforts to support executive decision-making and alignment
Partner with senior executives to define long-term strategic priorities and guide multi-year transformation roadmaps
Lead cross-functional teams on high-impact initiatives that shape organizational direction, beyond just operational projects
Lead the development and maintenance of centralized dashboards and reporting tools to track progress, risks, and benefits realization
Integrate and synthesize initiative updates across workstreams into a cohesive portfolio view
Monitor portfolio-level progress across budget, timelines, and delivery milestones; escalate cross-cutting risks and issues as needed
Maintain documentation integrity, version control, and audit readiness across transformation deliverables
Build strong, collaborative relationships with project managers, workstream leads, and senior leaders
Serve as a liaison between TMO leadership and workstream teams to clarify expectations, align priorities, and elevate risks or resource needs
Facilitate governance forums, including Transformation Steering Committee meetings and executive reviews, to maintain momentum and alignment
Provide strategic support and “SWAT” assistance to senior leaders as needed
Identify and mitigate risks and resistance to transformation initiatives
Synthesize complex data and updates into clear, compelling narratives that drive buy-in and transparency
Continuously improve communication tools, templates, and processes based on feedback and evolving needs
Serve as go-to-partner for workstream teams and leadership in providing project reporting, risk tracking, and decision-making inputs
Qualification
Required
Bachelor's degree is required; MBA strongly preferred
6-10+ years of progressive experience in Corporate Strategy, including significant tenure at a leading management consulting firm (e.g. McKinsey, BCG, Bain, or equivalent); prior transition to industry a plus
Management Consulting (MBB) experience with medical device and/or pharma industry focus strongly preferred
8+ years experience in project/program management, transformation leadership, or enterprise PMO
Demonstrated success advising/managing C-suite executives and driving large-scale transformation programs
Proven experience managing end-to-end transformation reporting cycles, including planning, execution, and post-review synthesis
Demonstrated success in supporting high-level governance forums, including Steering Committees and executive reviews, through structured preparation and delivery
Ability to lead integration of updates from multiple workstreams into a cohesive portfolio view of transformation progress and risks
Familiarity with benefit realization tracking, budget alignment, and delivery milestone monitoring at the enterprise level
Adept at identifying reporting risks or gaps and escalating issues for resolution in a timely, structured manner
Comfortable working under tight deadlines and adapting to evolving reporting requirements from leadership and stakeholders
Strong data handling, reporting, and transformation management office toolset knowledge
Clear communicator with ability to engage cross-functional teams
Experience in enterprise reporting, transformation support, or change initiatives
Strong attention to detail and problem-solving mindset
Comfort with ambiguity and managing multiple priorities
Demonstrated ability to synthesize large volumes of transformation data into clear, actionable insights for senior leadership
Skilled in developing and maintaining dashboards, reporting templates, and governance materials to support executive forums
Experience facilitating portfolio-level reporting cycles and version control processes across distributed teams
Track record of identifying and implementing improvements to reporting processes and tools based on evolving transformation needs
Benefits
Medical and dental coverage that start on day one
Insurance coverage for basic life, accident, short-term and long-term disability, and business travel accident insurance
Employee Stock Purchase Plan (ESPP), with the ability to purchase company stock at a discount
401(k) Retirement Savings Plan (RSP), with options for employee contributions and company matching
Flexible Spending Accounts
Educational assistance programs
Paid holidays
Paid time off ranging from 20 to 35 days based on length of service
Family and medical leaves of absence
Paid parental leave
Commuting benefits
Employee Discount Program
Employee Assistance Program (EAP)
Childcare benefits
Company
Baxter International Inc.
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world.
H1B Sponsorship
Baxter International Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (15)
2024 (10)
2023 (17)
2022 (18)
2021 (6)
2020 (14)
Funding
Current Stage
Public CompanyTotal Funding
$2.28BKey Investors
German Federal Ministry of Education and Research
2025-12-08Post Ipo Debt· $600M
2021-04-21Grant· $1.81M
2019-05-15Post Ipo Debt· $1.68B
Leadership Team
Recent News
Company data provided by crunchbase